Key result
Management of chronic stable angina includes lifestyle changes, revascularization, and pharmacologic treatments such as beta-blockers, nitrates, calcium-channel blockers, and ranolazine.
Provides a general overview of the management of chronic stable angina, including lifestyle, pharmacological, and revascularization strategies.
Offers synthesis of chronic stable angina therapies; leaves open comparative effectiveness questions for future trials.
Management of angina includes lifestyle changes and pharmacologic treatment to reduce cardiovascular risks, antianginal therapies (beta-blockers, long-acting nitrates, calcium-channel blockers, and — recently in the United States — ranolazine), and revascularization.
No takes yet. Share an insight, caveat, or question.
E. Magnus Ohman (2016) studied this question. Management of chronic stable angina includes lifestyle changes, revascularization, and pharmacologic treatments such as beta-blockers, nitrates, calcium-channel blockers, and ranolazine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: